Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Gastroenterology | Family Medicine
Clinical Trials: Gastric Cancer
A listing of clinical trials currently looking for volunteers to enroll in Gastric Cancer studies. Click on the closest city to find more detailed information on a research study in your area.
Arizona
Scottsdale : Site Reference ID/Investigator# 24987
Evaluating the Safety and Tolerability of the Poly-ADP Ribose (PARP) Inhibitor With FOLFIRI in Subjects With Solid Tumor
California
Beverly HIlls : Research Center
A clinical research study for patients with gastric cancer.
Beverly HIlls : Research Site
A clinical research study for patients with gastric cancer.
View More »
Duarte : City of Hope Cancer Center
Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
La Jolla :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Los Angeles :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Los Angeles : Site Reference ID/Investigator# 24985
Evaluating the Safety and Tolerability of the Poly-ADP Ribose (PARP) Inhibitor With FOLFIRI in Subjects With Solid Tumor
Stanford :
A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
Whittier :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Colorado
Denver :
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative Gastroesophageal Cancer
Denver : Research Site
First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma
Connecticut
Hamden : Medical Oncology & Hematology PC
FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer
New Haven : Yale University School of Medicine
FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer
District of Columbia
Washington : Site Reference ID/Investigator# 24986
Evaluating the Safety and Tolerability of the Poly-ADP Ribose (PARP) Inhibitor With FOLFIRI in Subjects With Solid Tumor
Florida
Jacksonville : Mayo Clinic
Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal Neoplasia
Pembroke Pines : Memorial Cancer Institute
Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
Georgia
Savannah : Memorial University Medical Center
SWOG S1005: A Phase II Study of MK-2206 (NSC-749607) as Second Line Therapy for Advanced Gastric and Gastroesophageal Junction Cancer.
View More »
Atlanta : Piedmont Hospital Research Institute
Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
Illinois
Elgin : Sherman Health
SWOG S1201 Phase II Randomized, Pilot Study of FOLFOX Therapy Comprising Oxaliplatin, Leucovorin Calcium, and Fluorouracil Versus Irinotecan Hydrochloride and Docetaxel in Patients With Advanced or Metastatic Esophageal Cancer, Gastric Cancer, or Gastroesophageal Junction Cancer
View More »
Chicago :
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative Gastroesophageal Cancer
Niles :
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative Gastroesophageal Cancer
Indiana
Goshen :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Kansas
Wichita :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Louisiana
Alexandria : Research Site
A clinical research study for patients with gastric cancer.
Maryland
Bethesda : National Cancer Institute
Safety Study of MGAH22 in HER2-positive Carcinomas
Massachusetts
Boston : Dana-Farber Cancer Institute
CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric Cancer
Boston : Massachusetts General Hospital
CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric Cancer
Boston : Massachusetts General Hospital Cancer Center
Safety Study of MGA271 in Refractory Cancer
Nebraska
Omaha : Nebraska Cancer Specialists, Methodist Estabrook Cancer Center
Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
New Jersey
Basking Ridge : Memoral Sloan Kettering Cancer Center
Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
New Mexico
Albuquerque : Research Site
A clinical research study for patients with gastric cancer.
Albuquerque : Research Center
A clinical research study for patients with gastric cancer.
New York
Albany :
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative Gastroesophageal Cancer
Commack : Memorial Sloan-Kettering Cancer Center @ Suffolk
Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
Jamaica : Queens Cancer Center of Queens Hospital
Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
New Hyde Park : Long Island Jewish Medical Center
Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
New York :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
View More »
New York :
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative Gastroesophageal Cancer
New York : Memorial Sloan-Kettering Cancer Center
Afatinib (BIBW 2992) in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer
New York : Memorial Sloan-Kettering Cancer Center
Evaluation of Respiratory Motion-Corrected Cone-Beam CT in Radiation Treatment of Thoracic and Abdominal Cancers
New York : Memorial Sloan-Kettering Cancer Center 1275 York Avenue
Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
New York : Weill Medical College of Cornell University
Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
Rockville Centre : Memorial Sloan-Kettering at Mercy Medical Center
Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
Sleepy Hollow : Memoral Sloan Kettering Cancer Center@Phelps Memorial Hospital
Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
North Carolina
Durham : Site Reference ID/Investigator# 24922
Evaluating the Safety and Tolerability of the Poly-ADP Ribose (PARP) Inhibitor With FOLFIRI in Subjects With Solid Tumor
Greensboro : Research Site
First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma
Winston Salem : Research Site
First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma
Ohio
Cincinnati :
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative Gastroesophageal Cancer
Oregon
Portland :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Pennsylvania
Hershey : Research Center
A clinical research study for patients with gastric cancer.
View More »
Philadelphia : Hospital of the University of Pennsylvania/Abramson Cancer Center
Safety Study of MGA271 in Refractory Cancer
Pittsburgh : University of Pittsburgh Cancer Institute
Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
Rockledge : Fox Chase Cancer Center
An A/B Dose Escalation Study of AbGn-7 Alone and With FOLFOX7 Treatment in Patients With Advanced Solid Tumors
South Carolina
Charleston : Research Center
A clinical research study for patients with gastric cancer.
Charleston : Research Site
A clinical research study for patients with gastric cancer.
View More »
Charleston :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Tennessee
Nashville :
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative Gastroesophageal Cancer
Nashville : Site Reference ID/Investigator# 24983
Evaluating the Safety and Tolerability of the Poly-ADP Ribose (PARP) Inhibitor With FOLFIRI in Subjects With Solid Tumor
Nashville : Sarah Cannon Research Institute
Safety Study of MGA271 in Refractory Cancer
Nashville : Sarah Cannon Research Institute
Safety Study of MGAH22 in HER2-positive Carcinomas
Texas
Dallas : Research Center
A clinical research study for patients with gastric cancer.
Houston : Research Site
A clinical research study for patients with gastric cancer.
View More »
Austin :
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative Gastroesophageal Cancer
Bedford :
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative Gastroesophageal Cancer
Bedford : Research Site
First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma
Dallas : Research Site
First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma
Garland :
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative Gastroesophageal Cancer
Houston : UT MD Anderson Cancer Center
Chemoradiation-Induced Nausea and Emesis: Quality of Life
San Antonio : The University of Texas Health Science Center-CTRC
An A/B Dose Escalation Study of AbGn-7 Alone and With FOLFOX7 Treatment in Patients With Advanced Solid Tumors
Tyler :
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative Gastroesophageal Cancer
Virginia
Fairfax :
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative Gastroesophageal Cancer
Richmond :
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative Gastroesophageal Cancer
Washington
Vancouver :
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative Gastroesophageal Cancer
Wisconsin
Milwaukee : Medical College of Wisconsin
Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
Argentina
Rosario : Research Site
A clinical research study for patients with gastric cancer.
Australia
East Bentleigh :
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative Gastroesophageal Cancer
Heidelberg :
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative Gastroesophageal Cancer
Herston :
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative Gastroesophageal Cancer
Kurralta Park : Research Site
First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma
Nedlands :
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative Gastroesophageal Cancer
View More »
Port Macquarie :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Wahroonga :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Woodville South :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Woodville South :
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative Gastroesophageal Cancer
Belgium
Bruxelles : Research Center
A clinical research study for patients with gastric cancer.
Edegem : Research Site
A clinical research study for patients with gastric cancer.
Gent : Research Center
A clinical research study for patients with gastric cancer.
Liège : Research Site
A clinical research study for patients with gastric cancer.
View More »
Brussels (anderlecht) : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Brussels (woluwe-st-lambert) : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Leuven : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Liege : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Brazil
Barretos : Research Site
A clinical research study for patients with gastric cancer.
Belo Horizonte : Research Site
A clinical research study for patients with gastric cancer.
Fortaleza : Research Site
A clinical research study for patients with gastric cancer.
IjuĂ : Research Site
A clinical research study for patients with gastric cancer.
Porto Alegre : Research Site
A clinical research study for patients with gastric cancer.
RibeirĂŁo Preto : Research Site
A clinical research study for patients with gastric cancer.
Salvador : Research Site
A clinical research study for patients with gastric cancer.
SĂŁo Paulo : Research Site
A clinical research study for patients with gastric cancer.
SĂŁo Paulo : Research Site
A clinical research study for patients with gastric cancer.
View More »
Barretos :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Rio de Janeiro :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Sorocaba :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Bulgaria
Gabrovo : Research Center
A clinical research study for patients with gastric cancer.
Pleven : Research Site
A clinical research study for patients with gastric cancer.
Varna : Research Center
A clinical research study for patients with gastric cancer.
Vratsa : Research Center
A clinical research study for patients with gastric cancer.
Canada
Brampton :
A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
East York :
A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
Laval : Research Site
First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma
Chile
Santiago :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Viña Del Mar :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
China
Beijing : Beijing Cancer Hospital
A Phaseâ…ˇ Study: SOX vs SP in Adjuvant Chemotherapy After D2 Surgery
Beijing :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Beijing : Beijing Cancer Hospital
Xeloda Plus Paclitaxel in Gastric Cancer With Liver Metastasis
Guangzhou :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Nanjing :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Colombia
Teusaquillo : Research Center
A clinical research study for patients with gastric cancer.
Croatia
Osijek : Research Center
A clinical research study for patients with gastric cancer.
Zagreb : Research Site
A clinical research study for patients with gastric cancer.
Czech Republic
Brno : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Hradec Kralove :
A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
Olomouc :
A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
Olomouc : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Praha :
A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
View More »
Praha 2 :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Praha 2 : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Praha 8 :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Estonia
Tallinn : Research Site
A clinical research study for patients with gastric cancer.
Tallinn : Research Site
A clinical research study for patients with gastric cancer.
France
Besancon :
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative And Met-Positive Gastroesophageal Cancer (MetGastric)
Paris :
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative And Met-Positive Gastroesophageal Cancer (MetGastric)
Toulouse :
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative And Met-Positive Gastroesophageal Cancer (MetGastric)
Villejuif : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Germany
Aachen : Research Center
A clinical research study for patients with gastric cancer.
Essen : Research Site
A clinical research study for patients with gastric cancer.
Herne, NRW : Research Site
A clinical research study for patients with gastric cancer.
Leverkusen : Research Center
A clinical research study for patients with gastric cancer.
Muenchen : Research Center
A clinical research study for patients with gastric cancer.
Trier, RP : Research Site
A clinical research study for patients with gastric cancer.
View More »
Berlin :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Frankfurt :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Frankfurt :
An Observational Study of Herceptin (Trastuzumab) in Patients With HER2-positive Advanced Gastric Cancer
Hamburg :
A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
Hamburg : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Landshut :
A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
Magedburg :
A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
Mainz : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Mannheim :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Mannheim :
A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer
Hungary
Budapest : Research Center
A clinical research study for patients with gastric cancer.
Gyor : Research Center
A clinical research study for patients with gastric cancer.
NyĂregyháza : Research Site
A clinical research study for patients with gastric cancer.
Pécs : Research Center
A clinical research study for patients with gastric cancer.
Szeged : Research Center
A clinical research study for patients with gastric cancer.
Székesfehérvár : Research Center
A clinical research study for patients with gastric cancer.
View More »
Budapest :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Budapest :
A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
Pecs :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Szeged :
A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
Szolnok :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Szolnok :
A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
Szombathely :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Veszprem :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Zalaegerszeg :
A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
India
Bangalore :
A Study of Herceptin (Trastuzumab) in Combination With Standard Chemotherapy in Patients With HER Positive Metastatic Gastric Cancer
Bangalore : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Chennai : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Chennai : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Hyderabad : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
View More »
Nagpur :
A Study of Herceptin (Trastuzumab) in Combination With Standard Chemotherapy in Patients With HER Positive Metastatic Gastric Cancer
Nagpur : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
New Delhi :
A Study of Herceptin (Trastuzumab) in Combination With Standard Chemotherapy in Patients With HER Positive Metastatic Gastric Cancer
Pune : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Vellore : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Vishakpatnam :
A Study of Herceptin (Trastuzumab) in Combination With Standard Chemotherapy in Patients With HER Positive Metastatic Gastric Cancer
Israel
Beer Sheva : Research Site
A clinical research study for patients with gastric cancer.
Jerusalem : Research Center
A clinical research study for patients with gastric cancer.
Kfar Saba : Research Center
A clinical research study for patients with gastric cancer.
Ramat Gan : Research Center
A clinical research study for patients with gastric cancer.
Tel Aviv : Research Center
A clinical research study for patients with gastric cancer.
Italy
Milano : Research Site
A clinical research study for patients with gastric cancer.
Milano : Research Center
A clinical research study for patients with gastric cancer.
Modena : Research Center
A clinical research study for patients with gastric cancer.
Potenza : Research Site
A clinical research study for patients with gastric cancer.
Reggio Emilia : Research Site
A clinical research study for patients with gastric cancer.
Rimini : Research Center
A clinical research study for patients with gastric cancer.
View More »
Ancona :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Ancona : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Bologna :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Catanzaro :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Firenze :
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative And Met-Positive Gastroesophageal Cancer (MetGastric)
Florence :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Milano :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Milano :
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative And Met-Positive Gastroesophageal Cancer (MetGastric)
Milano : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Pisa :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Pisa :
A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
Pisa : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Reggio Emilia :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Roma : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Udine :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Japan
Aichi :
A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
Chiba :
A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
Kashiwa :
A Phase I Study of E7050 in Subjects With Solid Tumors
Nagoya city :
A Phase I Study of E7050 in Subjects With Solid Tumors
Shizuoka city :
A Phase I Study of E7050 in Subjects With Solid Tumors
Korea, Republic of
Anyang : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Bundang City :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Daegu : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Incheon :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Jeonju : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
View More »
Jeonnam : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Seongnam : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Seoul :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Seoul :
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative Gastroesophageal Cancer
Seoul :
A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
Seoul : Investigational Site Number 410001
Cabazitaxel in Asian Patients With Advanced Gastric Cancer Who Failed Prior Chemotherapy
Seoul : Administrative Office
Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric Cancer
Seoul : Asan Medical Center
Dovitinib for Gastric Cancer With FGFR2 Amplification
Seoul : Seoul National University Hospital
Efficacy Study of Paclitaxel Versus Irinotecan in Patients With Recurrent or Metastatic Gastric Cancer Who Progress Following First-line Therapy
Seoul : Yonsei University Gangnam Severance Hospital
Efficacy Study of Paclitaxel Versus Irinotecan in Patients With Recurrent or Metastatic Gastric Cancer Who Progress Following First-line Therapy
Seoul : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Seoul : Seoul National University Hospital
Safety Study of MGAH22 in HER2-positive Carcinomas
Malaysia
Kuala Lumpur :
A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
Sabah :
A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
Mexico
Chihuahua : Research Center
A clinical research study for patients with gastric cancer.
Mexico City : Research Site
A clinical research study for patients with gastric cancer.
View More »
Distrito Federal :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Mexico City :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Monterrey :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Oaxaca :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Netherlands
Amsterdam : Nederlands Kanker Instituut/Antoni van Leeuwenhoek Ziekenhuis
Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer (CRITICS)
New Zealand
Auckland :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Panama
Panama :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Peru
Arequipa :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Lima :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Trujillo :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Philippines
Manila :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Pasig City :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Poland
Gdansk : Research Site
A clinical research study for patients with gastric cancer.
Lodz : Research Site
A clinical research study for patients with gastric cancer.
Olsztyn : Research Site
A clinical research study for patients with gastric cancer.
Szczecin : Research Site
A clinical research study for patients with gastric cancer.
Warszawa : Research Site
A clinical research study for patients with gastric cancer.
View More »
Krakow :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Warsaw :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Portugal
Aveiro : Research Center
A clinical research study for patients with gastric cancer.
Barreiro : Research Site
A clinical research study for patients with gastric cancer.
Coimbra : Research Center
A clinical research study for patients with gastric cancer.
Lisboa : Research Site
A clinical research study for patients with gastric cancer.
Porto : Research Site
A clinical research study for patients with gastric cancer.
View More »
Porto :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Romania
Baia Mare : Research Center
A clinical research study for patients with gastric cancer.
Cluj-Napoca : Research Site
A clinical research study for patients with gastric cancer.
Iasi : Research Center
A clinical research study for patients with gastric cancer.
Onesti : Research Center
A clinical research study for patients with gastric cancer.
Russia
Barnaul : Research Center
A clinical research study for patients with gastric cancer.
Moscow : Research Site
A clinical research study for patients with gastric cancer.
Saint Petersburg : Research Center
A clinical research study for patients with gastric cancer.
Saint Petersburg : Research Site
A clinical research study for patients with gastric cancer.
Saint-Petersburg : Research Site
A clinical research study for patients with gastric cancer.
Russian Federation
Ivanovo :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Ryazan :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
St Petersburg :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Stavropol :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Tula :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Serbia
Belgrade :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
NIS :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Sremska Kamenica :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Singapore
Singapore :
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative Gastroesophageal Cancer
Singapore :
A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
South Africa
Cape Town : Research Site
A clinical research study for patients with gastric cancer.
Cape Town : Research Site
A clinical research study for patients with gastric cancer.
Durban : Research Center
A clinical research study for patients with gastric cancer.
Groenkloof Pretoria : Research Center
A clinical research study for patients with gastric cancer.
Port Elisabeth : Research Site
A clinical research study for patients with gastric cancer.
Pretoria : Research Center
A clinical research study for patients with gastric cancer.
View More »
Johannesburg :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Spain
Barcelona : Research Site
A clinical research study for patients with gastric cancer.
Barcelona : Research Center
A clinical research study for patients with gastric cancer.
Barcelona : Research Center
A clinical research study for patients with gastric cancer.
Barcelona : Research Site
A clinical research study for patients with gastric cancer.
Barcelona : Research Site
A clinical research study for patients with gastric cancer.
Elche : Research Center
A clinical research study for patients with gastric cancer.
Madrid : Research Center
A clinical research study for patients with gastric cancer.
Madrid : Research Site
A clinical research study for patients with gastric cancer.
Madrid : Research Center
A clinical research study for patients with gastric cancer.
Madrid : Research Center
A clinical research study for patients with gastric cancer.
Madrid : Research Center
A clinical research study for patients with gastric cancer.
Malaga : Research Site
A clinical research study for patients with gastric cancer.
Sabadell : Research Center
A clinical research study for patients with gastric cancer.
Valencia : Research Center
A clinical research study for patients with gastric cancer.
View More »
Barcelona :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Barcelona :
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative And Met-Positive Gastroesophageal Cancer (MetGastric)
Barcelona :
A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
Barcelona : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
La Coruna : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Madrid :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Madrid :
A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
Madrid : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Oviedo : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Santander :
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative And Met-Positive Gastroesophageal Cancer (MetGastric)
Santander :
A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
Santiago de Compostela :
A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
Sevilla :
A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
Sevilla : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Valencia :
A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer
Zaragoza :
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative And Met-Positive Gastroesophageal Cancer (MetGastric)
Zaragoza :
A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
Taiwan
Taipei :
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative Gastroesophageal Cancer
Taipei : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Taiwan : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Thailand
Bangkok :
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative Gastroesophageal Cancer
Turkey
Adana :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Ankara :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Ankara :
A Study of the Combination of Oxaliplatin, Capecitabine and Herceptin (Trastuzumab) and Chemoradiotherapy in The Adjuvant Setting in Operated Patients With HER2+ Gastric or Gastro-Esophageal Junction Cancer (TOXAG Study)
Ankara :
A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
Gaziantep :
A Study of the Combination of Oxaliplatin, Capecitabine and Herceptin (Trastuzumab) and Chemoradiotherapy in The Adjuvant Setting in Operated Patients With HER2+ Gastric or Gastro-Esophageal Junction Cancer (TOXAG Study)
View More »
Istanbul :
A Study of the Combination of Oxaliplatin, Capecitabine and Herceptin (Trastuzumab) and Chemoradiotherapy in The Adjuvant Setting in Operated Patients With HER2+ Gastric or Gastro-Esophageal Junction Cancer (TOXAG Study)
Istanbul :
A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
Izmir :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Konya :
A Study of the Combination of Oxaliplatin, Capecitabine and Herceptin (Trastuzumab) and Chemoradiotherapy in The Adjuvant Setting in Operated Patients With HER2+ Gastric or Gastro-Esophageal Junction Cancer (TOXAG Study)
Ukraine
Cherkassy : Research Center
A clinical research study for patients with gastric cancer.
Chernivtsiy : Research Center
A clinical research study for patients with gastric cancer.
Dnepropetrovsk : Research Center
A clinical research study for patients with gastric cancer.
Donetsk : Research Center
A clinical research study for patients with gastric cancer.
Kharkiv : Research Center
A clinical research study for patients with gastric cancer.
Kyiv : Research Site
A clinical research study for patients with gastric cancer.
Lutsk : Research Center
A clinical research study for patients with gastric cancer.
Lviv : Research Center
A clinical research study for patients with gastric cancer.
Sumy : Research Center
A clinical research study for patients with gastric cancer.
Uzhgorod : Research Center
A clinical research study for patients with gastric cancer.
Zaporizzhya : Research Center
A clinical research study for patients with gastric cancer.
United Kingdom
London : Research Center
A clinical research study for patients with gastric cancer.
Rhyl : Research Center
A clinical research study for patients with gastric cancer.
View More »
Aberdeen : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Denbighshire :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Leicester :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
London :
A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
London : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Maidstone : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Manchester :
A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
Manchester : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Southampton :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Sutton :
A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
Sutton : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients
Wolverhampton :
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Wolverhampton : Research Site
Safety and Efficacy of AZD4547 Versus Paclitaxel in Advanced Gastric or Gastro-oesophageal Junction Cancer Patients